Abstract:
Context: Clinical verification is an ongoing research program of the Council that
verified many rare homoeopathic drugs.
Aims: To clinically verify the symptomatology of Mygale lasiodora by ascertaining the
symptoms improved during verification.
Settings and Design: In this multicenter observational study, 166 patients were
enrolled after matching with the available drug symptomatology and specified eligibility
criteria. The medicine was prescribed in 6C, 30C, 200C, and 1M potencies, as per
homoeopathic principles.
Statistical Analysis Used: Data were presented in terms of descriptive statistics.
Results: One sixty‑six cases were analyzed; male/female: 105/61; mean age
29.13 years. There were “clinical successes” in 104 cases and failures in 62, judged
subjectively by the physicians. A minimum of two prescriptions was considered for
pick‑listing each symptom as a rule of thumb. The number of symptoms verified was as
follows: proving symptoms (n = 18), symptoms from other literature (n = 16), and new
observations (n = 47). The data were presented as mean, standard deviations, N (%),
and 95% confidence intervals (CI).
Conclusions: Total 34 available symptoms were verified, and 47 new symptoms
were identified. Cautious interpretation is necessary. Further replication on larger
sample and estimation of likelihood ratio, in general, practice settings in prospective
Bayesian approach is necessary before inclusion of the symptoms in homoeopathic
literature.
